Benjamin Diamond, MD, on a Novel Quadruplet for Relapsed/Refractory Multiple Myeloma

December 08, 2025 By The ASCO Post Staff

Benjamin Diamond, MD, of the University of Miami, describes findings from the single-center phase II REKINDLE trial, which looked at the combination regimen of iberdomide, carfilzomib, daratumumab, and dexamethasone in patients with early relapsed/refractory multiple myeloma (Abstract 251). 

Related Content